Artoss Receives FDA Clearance to Market NanoBone SBX Putty

By Julie A. Vetalice

Artoss announced FDA 510(k) clearance to market NanoBone® SBX Putty.

NanoBone synthetic bone graft products have been used in Europe for ten years in nearly 400,000 clinical cases, across all indications. The newly-cleared product is exclusively distributed in North America by Artoss Inc., which launched the company's NanoBone Granule product in 2015.

Source: Artoss, Inc.

Product Labels: Synthetic Bone Graft

Tags: 510(k) Clearance, Regulatory